Table 6: Subgroup analysis of administered dose of intravenous iron (a marker of severity of iron-deficiency) and mean change (paired samples t-test differences) in pre- and post-intervention Patient Health Questionnaire-9 (PHQ-9) and Generalised Anxiety-Disorder-7 (GAD-7) scores.
Iron dose (mg) |
n |
Mean difference |
SD |
t |
p |
PHQ-9 (n = 81) |
|||||
1000 |
26 |
2.54 |
5.70 |
2.271 |
0.032 |
1500 |
30 |
4.03 |
4.67 |
4.729 |
< 0.001 |
2000 |
25 |
5.36 |
4.64 |
5.781 |
< 0.001 |
GAD-7 (n = 81) |
|||||
1000 |
26 |
1.81 |
2.99 |
3.08 |
0.005 |
1500 |
30 |
2.43 |
5.20 |
2.56 |
0.016 |
2000 |
25 |
2.88 |
2.99 |
4.82 |
< 0.001 |
SD: Standard Deviation